Efecto en la calidad de vida en pacientes con enfermedad venosa crónica posterior a realización de terapia esclerosante mediante la técnica de Tessari

Tablas, figuras

Autores:

Tipo de recurso:

Fecha de publicación:: 2025

Institución:: Universidad de Caldas

Repositorio:: Repositorio Institucional U. Caldas

Idioma:: spa

id	REPOUCALDA_1d5cb54fc3b84da50b7c3adbd7aa30bb
oai_identifier_str	oai:repositorio.ucaldas.edu.co:ucaldas/26309
network_acronym_str	REPOUCALDA
network_name_str	Repositorio Institucional U. Caldas
repository_id_str
dc.title.none.fl_str_mv	Efecto en la calidad de vida en pacientes con enfermedad venosa crónica posterior a realización de terapia esclerosante mediante la técnica de Tessari
title	Efecto en la calidad de vida en pacientes con enfermedad venosa crónica posterior a realización de terapia esclerosante mediante la técnica de Tessari
spellingShingle	Efecto en la calidad de vida en pacientes con enfermedad venosa crónica posterior a realización de terapia esclerosante mediante la técnica de Tessari 610 - Medicina y salud 3. Ciencias Médicas y de la Salud Calidad de Vida Venas Escleroterapia Polidocanol Várices Elastocompresión Cirugía Calidad de vida Necesidades básicas
title_short	Efecto en la calidad de vida en pacientes con enfermedad venosa crónica posterior a realización de terapia esclerosante mediante la técnica de Tessari
title_full	Efecto en la calidad de vida en pacientes con enfermedad venosa crónica posterior a realización de terapia esclerosante mediante la técnica de Tessari
title_fullStr	Efecto en la calidad de vida en pacientes con enfermedad venosa crónica posterior a realización de terapia esclerosante mediante la técnica de Tessari
title_full_unstemmed	Efecto en la calidad de vida en pacientes con enfermedad venosa crónica posterior a realización de terapia esclerosante mediante la técnica de Tessari
title_sort	Efecto en la calidad de vida en pacientes con enfermedad venosa crónica posterior a realización de terapia esclerosante mediante la técnica de Tessari
dc.contributor.none.fl_str_mv	GOMEZ VERA, CARLOS EDUARDO Arango, Fernando Villareal, Angel Ríos, Lukas Marcelo
dc.subject.none.fl_str_mv	610 - Medicina y salud 3. Ciencias Médicas y de la Salud Calidad de Vida Venas Escleroterapia Polidocanol Várices Elastocompresión Cirugía Calidad de vida Necesidades básicas
topic	610 - Medicina y salud 3. Ciencias Médicas y de la Salud Calidad de Vida Venas Escleroterapia Polidocanol Várices Elastocompresión Cirugía Calidad de vida Necesidades básicas
description	Tablas, figuras
publishDate	2025
dc.date.none.fl_str_mv	2025-11-27T13:57:02Z 2025-11-27T13:57:02Z 2025-11-26
dc.type.none.fl_str_mv	Trabajo de grado - Especialización http://purl.org/coar/resource_type/c_18ws Text info:eu-repo/semantics/report
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_93fc
dc.identifier.none.fl_str_mv	https://repositorio.ucaldas.edu.co/handle/ucaldas/26309 Universidad de Caldas Repositorio Institucional Universidad de Caldas repositorio.ucaldas.edu.co
url	https://repositorio.ucaldas.edu.co/handle/ucaldas/26309
identifier_str_mv	Universidad de Caldas Repositorio Institucional Universidad de Caldas repositorio.ucaldas.edu.co
dc.language.none.fl_str_mv	spa
language	spa
dc.relation.none.fl_str_mv	Sanka SA, Chryssofos S, Anolik RA, Sacks JM. Advances in Surgical Management of Chronic Lymphedema: Current Strategies and Future Directions. Medical Oncology (Northwood, London, England). 2025;42(2):44. DOI: 10.1007/s12032-024-02576-New Research Grada AA, Phillips TJ.Lymphedema: Pathophysiology and Clinical Manifestations.Journal of the Academy 10.1016/j.jaad.2017.03.022. of Dermatology. 2017;77(6):1009-1020. DOI: Bergan JJ, Bunke-Paquette N. Vein Book. 2a.ed. Oxford. Oxford University Press.2014; Chapter 1 Bergan JJ, Bunke-Paquette N. Vein Book. Second edition. Oxford. Oxford University Press; 2014. Chapter 3. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose vein.s. Ann Epidemiology. 2005; 15:175–184. DOI: 10.1016/j.annepidem.2004.05.015 Eberhardt R, Raffetto JD. Chronic Venous Insufficiency. Circulation. 2014; 130(4): 333-346. DOI: 10.1161/CIRCULATIONAHA.113.006898 Cronenwett J, Johnston K.W, Rutherford R. Rutherfords´s Vascular Surgery. Chronic Venous Disorders: General Considerations. Nigth Edition. Philadelphia. 2019; Chapter55 Gloviczki P, Lawrence PF, Wasan SM, et al. The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society Clinical Practice Guidelines for the Management of Varicose Veins of the Lower Extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine. Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2024;12(1):101670. doi:10.1016/j.jvsv.2023.08.011 Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/¬American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2016;34(6):611-35. Denlinger CS, Sanft T, Baker KS, et al. Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN. 2018;16(10):1216-1247 Vlajinac, HD, Radak, ÐJ, Marinković JM, Maksimović MŽ. Risk factors for chronic venous disease. Phlebology: The Journal of Venous Disease; 27(8), 416–422. DOI: 10.1258/phleb.2011.011091 Abbad CM, Horcajo RR, Ballesteros-Ortega MD. Guía de práctica clínica en enfermedad venosa crónica del Capítulo de Flebología y Linfología de la Sociedad Española de Angiología y Cirugía Vascular. Angiología. 2015; 68(1):55-62. DOI: 10.1016/j.angio.2015.09.011 Paty J, Turner-Bowker DM, Elash CA, Wright D. The VVSymQ_ instrument: Use of a new patient reported outcome measure for assessment of varicose vein symptoms. Phlebology 2016, Vol. 31(7) 481–488. DOI: 10.1177/0268355515595193 Paty J. VVSymQ™ and patient profiles: interpreting a new patient-reported outcome (PRO) instrument for great saphenous vein incompetence (GSVI). J Vasc Interv Radiol 2014;25(3): S101. 216. DOI: 10.1016/j.jvir.2013.12.283 Shumaker S, Naughton M. The International Assessment of Health-Related Quality of Life: a theoretical perspective. En: Shumaker S, Berson R, editors. The international assessment of health-related quality of life: theory, translation, measurement and analysis. Oxford: Rapid Communications, 1995. K. G. Klussmann, Francia Madrid, Angélica Blanco. Calidad de vida relacionada con la salud en pacientes con insuficiencia venosa crónica, Universidad de San Carlos de Guatemala Facultad de Ciencias Médicas, Trabajo de grado, Guatemala, septiembre de 2019 https://biblioteca.medicina.usac.edu.gt/tesis/pre/2019/053.pdf Jorge A Jaramillo, Rafael López. Determinación de la calidad de vida de los pacientes con trastornos venosos crónicos superficiales de miembros inferiores mediante la aplicación del cuestionario específico (CIVIQ-14) en tres hospitales de Quito. Ecuador. 2014, https://www.dspace.uce.edu.ec/server/api/core/bitstreams/785cc43f-8b0e-4fb6-b26a-378dedff8254 Dian Andriani Ratna Dewi, Abraham Arimuko, Lilik Norawati. Cureus. Effectiveness of Sclerotherapy to Cure Lower Limb Chronic Venous Insufficiency Grades 1-6: A Systematic Review and Meta-Analysis. 2023 Dec 1;15(12): e49770. doi: 10.7759/cureus.49770 Romero R, Gomez C, Impacto de la calidad de vida en los pacientes con enfermedad venosa de Universidad de miembros inferiores posterior a safenovaricectomia. Repositorio digital Caldas. Trabajo de grado, 2022 Aber A, Poku E, Phillips P, Essat M, Buckley-Woods H, Palfreyman S. Systematic review of patient reported outcome measures in patients with varicose veins. British Journal of Surgery. 2017; 104(11), 1424–1432. DOI: 10.1002/bjs.10639 J. Cabrera Garrido. La escleroterapia con espuma es un método eficaz para el tratamiento de la insuficiencia venosa. Clínicas Dr. Juan Cabrera, Granada, Madrid, Barcelona y La Coruña, España. DOI: 10.1016/j.angio.2016.01.011 Salim S, Machin M, Patterson BO, Onida S, Davies AH. Global Epidemiology of Chronic Venous Disease: A Systematic Review With Pooled Prevalence Analysis. Annals of Surgery. 2021;274(6):971-976. doi:10.1097/SLA.0000000000004631 Rochon PJ, Reghunathan A, Kapoor BS, et al.ACR Appropriateness Criteria® Lower Extremity Chronic Venous Disease. Rochon PJ, Reghunathan A, Kapoor BS, et al. Journal of the American College of Radiology: JACR. 2023;20(11S): S481-S500. doi: 10.1016/j.jacr.2023.08.011 Gloviczki P, Come Rota AJ, Dallying MC, et al. The Care of Patients with Varicose Veins and Associated Chronic Venous Diseases: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum. Journal of Vascular Surgery. 2011;53(5 Suppl):2S-48S. doi:10.1016/j.jvs.2011.01.079. Rabe E, et al: The VCP Coordinators: Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012; 31:105–115. PMID: 22466974 Dimakakos, E., Syrigos, K., Scliros, E. Karaitianos, I. Prevalence, risk and aggravating factors of chronic venous disease: an epidemiological survey of the general population of Greece. Phlebology, 2013; 28(4), 184–190. DOI: 10.1258/phleb.2011.011143 Rial Horcajo R, Serrano FJ. Moñux Ducajú G. Reina T. Martín A. Enfermedad venosa crónica. Conceptos actuales y avances terapéuticos. Medicine. 2017;12(41), 2448–2457. DOI: 10.1016/j.med.2017.09.013 Noel AA, Gloviczki P, Cherry KJ, Rooke TW, Stanson AW, Driscoll DJ. Surgical treatment of venous malformations in Klippel-Trénaunay syndrome. J Vasc Surg. 2000; 32:840–847. DOI: 10.1067/mva.2000.110343 Killewich LA, Bedford GR, Beach KW, Strandness DE Jr. Spontaneous lysis of deep venous thrombi: rate and outcome. J Vasc Surg 1989; 9:89-97. PMID: 2911146 Gujja, K., Sanina, C., & Wiley, J. M. Chronic Venous Insufficiency. Interventional Cardiology. 2016; 759–767. DOI: 10.1016/j.iccl.2014.07.001 Fowkes FG, Evans CJ, Lee AJ. Prevalence and risk factors for chronic venous insufficiency. Angiology. 2001;52: S5–S15. DOI: 10.1177/0003319701052001S02 Cediel. Semiología Medica. Editorial Celsus 2015.Bogotá. Colombia Porter JM, Moneta GL. Reporting standards in venous disease: an update– International Consensus Committee on Chronic Venous Disease. J Vasc Surg. 1995; 21:635–645. DOI: 10.1016/s0741 5214(95)70195-8 Lurie F, Passman M, Meisner M, Dalsing M. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020 May;8(3):342-35. DOI: 10.1016/j.jvsv.2019.12.075 Rutherford RB, Padberg FT, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg. 2000; 31:1307–1312. DOI: 10.1067/mva.2000.107094 Carman TL, Al-Omari A. Evaluation and Management of Chronic Venous Disease Using the Foundation of CEAP. Current Cardiology Reports. 2019;21(10). DOI: 10.1007/s11886-019-1201-1 Criado E, Farber MA, Marston WA, Daniel PF, Burnham CB, Keagy BA. The role of air plethysmography in the diagnosis of chronic venous insufficiency. J Vasc Surg 1998; 27:660-670. DOI: 10.1016/s0741-5214(98)70231-9 Carrasco OF, Ranero A, Hong E, Vidrio H. Endothelial function impairment in chronic venous insufficiency: effect of some cardiovascular protectant agents. Angiology. 2010; 60(6):763-71. DOI: 10.1177/0003319709332108 Youn YJ, Lee J. Chronic venous insufficiency and varicose veins of the lower extremities. The Korean Journal of Internal Medicine. 2019. 34(2), 269–283. DOI: 10.3904/kjim.2018.230 Motykie GD, Caprini JA, Arcelus JI, Reyna JJ, Overom E, Mokhtee D. Evaluation of therapeutic compression stockings in the treatment of chronic venous insufficiency. Dermatol Surg. 1999; 25:116 120. doi: 10.1046/j.1524- 4725.1999.08095.x Nicolaides A, Kakkos S, Baekgaard N. Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part I. Int Angiol. 2018; 37(3):181-254. DOI: 10.23736/S0392-9590.18.03999-8 Killewich LA, Bedford GR, Beach KW, Strandness DE Jr. Spontaneous lysis of deep venous thrombi: rate and outcome. J Vasc Surg 1989; 9:89-97. PMID: 2911146 Sansilvestri-Morel P, Rupin A, Jaisson S, Fabiani JN, Verbeuren TJ, Vanhoutte PM. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation 2002; 10.1161/01.cir.0000022846.22923.46 Davis HA, Lim CS, Natural history and progression of primary chronic venous disorder. Journal of Vascular Surgery. 2010; 52(14) O’Donnell T, Passman MA, Marston WA, Ennis W, Dalsing M, Kistner RL, Gloviczki P. Management of venous leg ulcers: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. Journal of Vascular Surgery. 2014; 60(2), 3S–59S. DOI: 10.1016/j.jvs.2014.04.049 White JV, Ryjewski C. Chronic venous insufficiency. Perspect Vasc Surg Endovasc Ther. 2005;17(4):319-27. DOI: 10.1177/153100350501700406 D.M. Eckmann, S. Kobayashi, M. Li. Microvascular embolization following polidocanol microfoam sclerosant administration. Dermatol Surg, 31 (2005), pp. 636-643 Cabrera Garrido, J. La escleroterapia con espuma es un método eficaz para el tratamiento de la insuficiencia venosa. 2016 JOUR Angiología.10.1016/j.angio.2016.01.011 Nesbitt C, Bedenis R, Bhattacharya V, Stansby G. Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database of Systematic Reviews. 2014. DOI: 10.1002/14651858.CD005624.pub3 MacKenzie RK, Allan PL, Ruckley CV, Bradbury AW. The effect of long saphenous vein stripping on deep venous reflux. Eur J Vasc Endovasc Surg. 2004; 28:104–107. DOI: 10.1016/j.ejvs.2004.03.009 Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg 2011;98(8):1079-87. DOI: 10.1002/bjs.7555 López-Otín C, Kroemer G.Hallmarks of Health.Cell. 2021;184(1):33-63. doi:10.1016/j.cell.2020.11.034 Kaplan R, Criqui M, Denenberg J, Bergan J, Fronek A. Quality of life in patients with chronic venous disease: San Diego population study. Journal of Vascular Surgery 2003; 37: 1047-1053. DOI: 10.1067/mva.2003.168 Phyo AZZ, Freak-Poli R, Craig H, et al. Quality of Life and Mortality in the General Population: A Systematic Review and Meta-Analysis.BMC Public Health. 2020;20(1):1596. doi:10.1186/s12889-020 09639-9. Paty J, Turner-Bowker DM, Elash CA, Wright D. The VVSymQ_ instrument: Use of a new patient reported outcome measure for assessment of varicose vein symptoms. Phlebology 2016, Vol. 31(7) 481–488. DOI: 10.1177/0268355515595193 Perales F, del Pozo-Cruz J, del Pozo-Cruz J, del Pozo-Cruz B. On the Associations Between Physical Activity and Quality of Life: Findings from an Australian Nationally Representative Panel Survey.Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 2014;23(7):1921-33. doi:10.1007/s11136-014-0645-4. Kiełtyka-Słowik A, Michalik-Marcinkowska U, Zawadzka B. The Association Between Physical Activity and Quality of Life Among People Aged 60-89 Living in Own Homes and Nursing Homes.BMC Geriatrics. 2024;24(1):280. doi:10.1186/s12877-024-04898-2. VILAGUT, Gemma RED-IRYSS et al. El Cuestionario de Salud SF-36 español: una decada de experiencia y nuevos desarrollos. Gac Sanit [online]. 2005, vol.19, n.2, pp.135-150. ISSN 0213-9111 Calidad de vida en salud en pacientes con insuficiencia venosa mixta luego de varicosafenectomia, JA Sánchez Monroy. Universidad del Rosario. 2012. http://repository.urosario.edu.co/handle/10336/3629 Lamping DL, Schroter S, Kurz X, et al. Evaluation of outcomes in chronic venous disorders of the leg: developmentof a scientifically rigorous, patient- reported measure of symptoms and quality of life. J Vasc Surg 2003; 37: 410–419. DOI: 10.1067/mva.2003.152 Rabe E, Pannier F. Societal costs of chronic venous disease in CEAP C4, C5, C6 disease. Phlebology: The Journal of Venous Disease. 2010 25 (S1), 64–67. DOI: 10.1258/phleb.2010.010s09 Jaramillo-Vergara V, Carrasco-Uruchima P. Calidad de vida en personas con diagnóstico de insuficiencia venosa crónica que se encuentran en espera de cirugía venosa en el Hospital Eugenio Espejo en el año 2015. Repositorio digital Universidad central del http://www.dspace.uce.edu.ec/handle/25000/10588 Todd KL, Wright DI and the VANISH-2 Investigators. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence. Phlebology 2014; 29: 608–618. DOI: 10.1177/0268355513497709 VANISH-1: Phase III Study of Polidocanol Endovenous Microfoam on the Appearance of Varicose Veins. Podium presentation by Theodore King, Am Coll Phlebology, 2012 Paty J. Elash C, Turner-Bowker D. Content Validity for the VVSymQ Instrument: A New Patient Reported Outcome Measure for the Assessment of Varicose Veins Symptoms Jean. Patient.2017; 10:51–63. DOI: 10.1007/s40271-016-0183-y Aber A, Poku E, Phillips P, Essat M, Buckley-Woods H, Palfreyman S. Systematic review of patient reported outcome measures in patients with varicose veins. British Journal of Surgery. 2017; 104(11), 1424–1432. DOI: 10.1002/bjs.10639 Dian Andriani Ratna Dewi, Abraham Arimuko, Lilik Norawati. Cureus. Effectiveness of Sclerotherapy to Cure Lower Limb Chronic Venous Insufficiency Grades 1-6: A Systematic Review and Meta Analysis. 2023 Dec 1;15(12): e49770. doi: 10.7759/cureus.49770 Paty J, Turner Bowker DM, et al. The VVSymQ® instrument: use of a new patient reported outcome measure for varicose vein symptoms. Phlebology. 2015;30(8):534 45. doi:10.1177/0268355515595193. Sakugawa LS, Portela FSO, Louzada ACS, et al. Polidocanol foam treatment of varicose veins: quality of life impact compared to conventional surgery. Clinics (Sao Paulo). 2024; 79:100346. doi: 10.1016/j.clinsp.2024.100346 Todd KL, Wright DI; VANISH 2 Investigators. Durability of treatment effect with polidocanol endovenous microfoam on varicose vein symptoms and appearance (VANISH 2). J Vasc Interv Radiol. 2015;26(5):571 8. doi: 10.1016/j.jvir.2015.02.027 Ardeleanu V, Moroianu LA, Curis C, Tatu AL, Ardeleanu IR. The usage of polidocanol in varicose disease treatment. Diagnostics (Basel). 2024;11(2):62. doi:10.3390/diagnostics11020062 Rodríguez Garcés CA. La Enfermedad Varicosa. Su tratamiento con radioesclerosis. Rev Colomb Cir. 1998;13(2):104–113. Disponible en: Revista Colombiana de Cirugía, Vol. 13 Núm. 2 (1998) Banchieri A, Betancur J, Bonelli G, Buenahora Y, Castro P, Russo F; supervisores Otero G, Sarutte S, Volpi M. Estudio descriptivo de escleroterapia con polidocanol en pacientes con insuficiencia venosa crónica, entre julio–octubre 2018 en Hospital de Clínicas [Monografía]. Montevideo: Universidad de la https://hdl.handle.net/20.500.12008/33342 República; 2018. Disponible en:
dc.rights.none.fl_str_mv	https://creativecommons.org/licenses/by-nc-nd/4.0/ Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
dc.rights.coar.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	https://creativecommons.org/licenses/by-nc-nd/4.0/ Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) http://purl.org/coar/access_right/c_abf2
dc.format.none.fl_str_mv	47 páginas application/pdf application/pdf application/pdf application/pdf
dc.publisher.none.fl_str_mv	Universidad de Caldas Facultad de Ciencias para la Salud Manizales Caldas Especialización en Cirugía General
publisher.none.fl_str_mv	Universidad de Caldas Facultad de Ciencias para la Salud Manizales Caldas Especialización en Cirugía General
institution	Universidad de Caldas
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_	1866404481990656000
spelling	Efecto en la calidad de vida en pacientes con enfermedad venosa crónica posterior a realización de terapia esclerosante mediante la técnica de Tessari610 - Medicina y salud3. Ciencias Médicas y de la SaludCalidad de VidaVenasEscleroterapiaPolidocanolVáricesElastocompresiónCirugíaCalidad de vidaNecesidades básicasTablas, figurasIntroducción: La enfermedad venosa crónica(EVC) es una patología con alta demanda en procedimientos diagnósticos y terapéuticos, por su alta prevalencia y amplias posibilidades quirúrgicas. La Terapia Esclerosante con Polidocanol (TEP) ha sido ampliamente utilizada, con mejoría sintomática y clínica significativa con un impacto directo en la mejoría de la calidad de vida de los pacientes. Métodos y objetivo: Estudio de cohortes prospectivo con aplicación de encuesta calidad de vida (VVSymQ) de manera secuencial en los pacientes con diagnóstico EVC sometidos a TEP para determinar el impacto en calidad de vida posterior al tratamiento. Se realizó en la ciudad de Manizales de mayo a julio de 2025. Resultados: 128 pacientes evaluados, mediana edad fue 62 años, el 82,8% fueron mujeres, el 89.1% tenían una presentación severa de EVC con presentación homogénea de síntomas al momento pre quirúrgico. Se determinó que a la semana posquirúrgica hubo una disminución en síntomas, teniendo 5.4 % de los pacientes una presentación severa, 64.1% moderada y 30.5%; Tendencia de disminución al mes y a los tres meses posteriores a intervención, a los tres meses el 100% de los evaluados tenían una presentación leve de EVC con respecto a calidad de vida y sintomatología (p< 0.001). Conclusiones: La TEP mediante técnica de Tessari es una técnica útil y con buenos resultados a través del tiempo en mejoría de la sintomatología y calidad de vida en los pacientes con diagnóstico de ECV. Palabras clave: Calidad de Vida, Insuficiencia Venosa, Escleroterapia, Polidocanol, Venas Varicosas.Background: In Peripheral Vascular Surgery, chronic venous disease has become a pathology with high demand in diagnostic and therapeutic procedures given its high prevalence and in the same sense the wide possibility of options within the medical / surgical panel. Sclerosing Therapy with Polidocanol is one of the most used therapeutic options, with significant symptomatic and clinical improvement with a direct impact on the improvement of the quality of life in health of patients. Methods and objective: A study was carried out with a quantitative, prospective, longitudinal, analytical cohort design, a health quality survey was applied sequentially in patients undergoing percutaneous Sclerosing therapy in Manizales city, period of time May and July 2025. Results: 128 patients were evaluated, with a mean age of 62 years. 82.8% were women, 17.2% men, 89% had a family history of severe venous disease. With a homogeneous presentation of symptoms at the time of diagnosis, at one week postoperative there was a 50% decrease in all symptoms (heaviness, palpitations, edema and pain). At one month postoperative, 70.3% of the evaluated patients had symptoms classified as mild venous disease and 29.7% were classified as moderate venous disease. At three months postoperative, 100% of the evaluated patients improved their condition to mild venous disease, and improvement in all symptoms could be observed throughout the follow-up time (p = < 0.001). Adherence to continuous elastocompression in severe disease reached 63.2% and intermittent in 15.8%. Conclusions: Percutaneous sclerosis with Polidocanol using the Tessari technique is a useful technique with good results over time, in improving the symptoms of chronic venous disease with a good effect on the quality of life of the patients evaluated. Keywords: Quality of Life, Venous Insufficiency, Sclerotherapy, Polidocanol, Varicose Veins.Resumen -- Introducción -- Pregunta de investigación -- Objetivos -- Hipótesis -- Metodología -- Población -- Análisis de datos -- Consideraciones éticas -- Marco teórico -- Resultados -- Discusión -- Limitaciones -- Conclusiones -- Glosario -- Índice de figuras -- Índice de tablas -- Índice de gráficos -- Bibliografía -- AnexosEspecializaciónEstudio con diseño cuantitativo, prospectivo, longitudinal, analítico de cohortes. En el que se realizó una encuesta de calidad de vida con resultados en salud de manera secuencial a pacientes con enfermedad venosa crónica sometidos a terapia esclerosante vía percutánea en IPS de tercer nivel de la Ciudad de Manizales, Clínica AVIDANTI, en un período de tiempo comprendido entre mayo y julio de 2025.Especialista en Cirugía GeneralCirugía VascularUniversidad de CaldasFacultad de Ciencias para la SaludManizales CaldasEspecialización en Cirugía GeneralGOMEZ VERA, CARLOS EDUARDOArango, FernandoVillareal, AngelRíos, Lukas MarceloVillamil Alzate, David Alexander2025-11-27T13:57:02Z2025-11-27T13:57:02Z2025-11-26Trabajo de grado - Especializaciónhttp://purl.org/coar/resource_type/c_18wsTextinfo:eu-repo/semantics/reporthttp://purl.org/coar/resource_type/c_93fc47 páginasapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttps://repositorio.ucaldas.edu.co/handle/ucaldas/26309Universidad de CaldasRepositorio Institucional Universidad de Caldasrepositorio.ucaldas.edu.cospaSanka SA, Chryssofos S, Anolik RA, Sacks JM. Advances in Surgical Management of Chronic Lymphedema: Current Strategies and Future Directions. Medical Oncology (Northwood, London, England). 2025;42(2):44. DOI: 10.1007/s12032-024-02576-New ResearchGrada AA, Phillips TJ.Lymphedema: Pathophysiology and Clinical Manifestations.Journal of the Academy 10.1016/j.jaad.2017.03.022. of Dermatology. 2017;77(6):1009-1020. DOI:Bergan JJ, Bunke-Paquette N. Vein Book. 2a.ed. Oxford. Oxford University Press.2014; Chapter 1Bergan JJ, Bunke-Paquette N. Vein Book. Second edition. Oxford. Oxford University Press; 2014. Chapter 3.Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose vein.s. Ann Epidemiology. 2005; 15:175–184. DOI: 10.1016/j.annepidem.2004.05.015Eberhardt R, Raffetto JD. Chronic Venous Insufficiency. Circulation. 2014; 130(4): 333-346. DOI: 10.1161/CIRCULATIONAHA.113.006898Cronenwett J, Johnston K.W, Rutherford R. Rutherfords´s Vascular Surgery. Chronic Venous Disorders: General Considerations. Nigth Edition. Philadelphia. 2019; Chapter55Gloviczki P, Lawrence PF, Wasan SM, et al. The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society Clinical Practice Guidelines for the Management of Varicose Veins of the Lower Extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine. Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2024;12(1):101670. doi:10.1016/j.jvsv.2023.08.011Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/¬American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2016;34(6):611-35.Denlinger CS, Sanft T, Baker KS, et al. Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN. 2018;16(10):1216-1247Vlajinac, HD, Radak, ÐJ, Marinković JM, Maksimović MŽ. Risk factors for chronic venous disease. Phlebology: The Journal of Venous Disease; 27(8), 416–422. DOI: 10.1258/phleb.2011.011091Abbad CM, Horcajo RR, Ballesteros-Ortega MD. Guía de práctica clínica en enfermedad venosa crónica del Capítulo de Flebología y Linfología de la Sociedad Española de Angiología y Cirugía Vascular. Angiología. 2015; 68(1):55-62. DOI: 10.1016/j.angio.2015.09.011Paty J, Turner-Bowker DM, Elash CA, Wright D. The VVSymQ_ instrument: Use of a new patient reported outcome measure for assessment of varicose vein symptoms. Phlebology 2016, Vol. 31(7) 481–488. DOI: 10.1177/0268355515595193Paty J. VVSymQ™ and patient profiles: interpreting a new patient-reported outcome (PRO) instrument for great saphenous vein incompetence (GSVI). J Vasc Interv Radiol 2014;25(3): S101. 216. DOI: 10.1016/j.jvir.2013.12.283Shumaker S, Naughton M. The International Assessment of Health-Related Quality of Life: a theoretical perspective. En: Shumaker S, Berson R, editors. The international assessment of health-related quality of life: theory, translation, measurement and analysis. Oxford: Rapid Communications, 1995.K. G. Klussmann, Francia Madrid, Angélica Blanco. Calidad de vida relacionada con la salud en pacientes con insuficiencia venosa crónica, Universidad de San Carlos de Guatemala Facultad de Ciencias Médicas, Trabajo de grado, Guatemala, septiembre de 2019 https://biblioteca.medicina.usac.edu.gt/tesis/pre/2019/053.pdfJorge A Jaramillo, Rafael López. Determinación de la calidad de vida de los pacientes con trastornos venosos crónicos superficiales de miembros inferiores mediante la aplicación del cuestionario específico (CIVIQ-14) en tres hospitales de Quito. Ecuador. 2014, https://www.dspace.uce.edu.ec/server/api/core/bitstreams/785cc43f-8b0e-4fb6-b26a-378dedff8254Dian Andriani Ratna Dewi, Abraham Arimuko, Lilik Norawati. Cureus. Effectiveness of Sclerotherapy to Cure Lower Limb Chronic Venous Insufficiency Grades 1-6: A Systematic Review and Meta-Analysis. 2023 Dec 1;15(12): e49770. doi: 10.7759/cureus.49770Romero R, Gomez C, Impacto de la calidad de vida en los pacientes con enfermedad venosa de Universidad de miembros inferiores posterior a safenovaricectomia. Repositorio digital Caldas. Trabajo de grado, 2022Aber A, Poku E, Phillips P, Essat M, Buckley-Woods H, Palfreyman S. Systematic review of patient reported outcome measures in patients with varicose veins. British Journal of Surgery. 2017; 104(11), 1424–1432. DOI: 10.1002/bjs.10639J. Cabrera Garrido. La escleroterapia con espuma es un método eficaz para el tratamiento de la insuficiencia venosa. Clínicas Dr. Juan Cabrera, Granada, Madrid, Barcelona y La Coruña, España. DOI: 10.1016/j.angio.2016.01.011Salim S, Machin M, Patterson BO, Onida S, Davies AH. Global Epidemiology of Chronic Venous Disease: A Systematic Review With Pooled Prevalence Analysis. Annals of Surgery. 2021;274(6):971-976. doi:10.1097/SLA.0000000000004631Rochon PJ, Reghunathan A, Kapoor BS, et al.ACR Appropriateness Criteria® Lower Extremity Chronic Venous Disease. Rochon PJ, Reghunathan A, Kapoor BS, et al. Journal of the American College of Radiology: JACR. 2023;20(11S): S481-S500. doi: 10.1016/j.jacr.2023.08.011Gloviczki P, Come Rota AJ, Dallying MC, et al. The Care of Patients with Varicose Veins and Associated Chronic Venous Diseases: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum. Journal of Vascular Surgery. 2011;53(5 Suppl):2S-48S. doi:10.1016/j.jvs.2011.01.079.Rabe E, et al: The VCP Coordinators: Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012; 31:105–115. PMID: 22466974Dimakakos, E., Syrigos, K., Scliros, E. Karaitianos, I. Prevalence, risk and aggravating factors of chronic venous disease: an epidemiological survey of the general population of Greece. Phlebology, 2013; 28(4), 184–190. DOI: 10.1258/phleb.2011.011143Rial Horcajo R, Serrano FJ. Moñux Ducajú G. Reina T. Martín A. Enfermedad venosa crónica. Conceptos actuales y avances terapéuticos. Medicine. 2017;12(41), 2448–2457. DOI: 10.1016/j.med.2017.09.013Noel AA, Gloviczki P, Cherry KJ, Rooke TW, Stanson AW, Driscoll DJ. Surgical treatment of venous malformations in Klippel-Trénaunay syndrome. J Vasc Surg. 2000; 32:840–847. DOI: 10.1067/mva.2000.110343Killewich LA, Bedford GR, Beach KW, Strandness DE Jr. Spontaneous lysis of deep venous thrombi: rate and outcome. J Vasc Surg 1989; 9:89-97. PMID: 2911146Gujja, K., Sanina, C., & Wiley, J. M. Chronic Venous Insufficiency. Interventional Cardiology. 2016; 759–767. DOI: 10.1016/j.iccl.2014.07.001Fowkes FG, Evans CJ, Lee AJ. Prevalence and risk factors for chronic venous insufficiency. Angiology. 2001;52: S5–S15. DOI: 10.1177/0003319701052001S02Cediel. Semiología Medica. Editorial Celsus 2015.Bogotá. ColombiaPorter JM, Moneta GL. Reporting standards in venous disease: an update– International Consensus Committee on Chronic Venous Disease. J Vasc Surg. 1995; 21:635–645. DOI: 10.1016/s0741 5214(95)70195-8Lurie F, Passman M, Meisner M, Dalsing M. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020 May;8(3):342-35. DOI: 10.1016/j.jvsv.2019.12.075Rutherford RB, Padberg FT, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg. 2000; 31:1307–1312. DOI: 10.1067/mva.2000.107094Carman TL, Al-Omari A. Evaluation and Management of Chronic Venous Disease Using the Foundation of CEAP. Current Cardiology Reports. 2019;21(10). DOI: 10.1007/s11886-019-1201-1Criado E, Farber MA, Marston WA, Daniel PF, Burnham CB, Keagy BA. The role of air plethysmography in the diagnosis of chronic venous insufficiency. J Vasc Surg 1998; 27:660-670. DOI: 10.1016/s0741-5214(98)70231-9Carrasco OF, Ranero A, Hong E, Vidrio H. Endothelial function impairment in chronic venous insufficiency: effect of some cardiovascular protectant agents. Angiology. 2010; 60(6):763-71. DOI: 10.1177/0003319709332108Youn YJ, Lee J. Chronic venous insufficiency and varicose veins of the lower extremities. The Korean Journal of Internal Medicine. 2019. 34(2), 269–283. DOI: 10.3904/kjim.2018.230Motykie GD, Caprini JA, Arcelus JI, Reyna JJ, Overom E, Mokhtee D. Evaluation of therapeutic compression stockings in the treatment of chronic venous insufficiency. Dermatol Surg. 1999; 25:116 120. doi: 10.1046/j.1524- 4725.1999.08095.xNicolaides A, Kakkos S, Baekgaard N. Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part I. Int Angiol. 2018; 37(3):181-254. DOI: 10.23736/S0392-9590.18.03999-8Killewich LA, Bedford GR, Beach KW, Strandness DE Jr. Spontaneous lysis of deep venous thrombi: rate and outcome. J Vasc Surg 1989; 9:89-97. PMID: 2911146Sansilvestri-Morel P, Rupin A, Jaisson S, Fabiani JN, Verbeuren TJ, Vanhoutte PM. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation 2002; 10.1161/01.cir.0000022846.22923.46Davis HA, Lim CS, Natural history and progression of primary chronic venous disorder. Journal of Vascular Surgery. 2010; 52(14)O’Donnell T, Passman MA, Marston WA, Ennis W, Dalsing M, Kistner RL, Gloviczki P. Management of venous leg ulcers: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. Journal of Vascular Surgery. 2014; 60(2), 3S–59S. DOI: 10.1016/j.jvs.2014.04.049White JV, Ryjewski C. Chronic venous insufficiency. Perspect Vasc Surg Endovasc Ther. 2005;17(4):319-27. DOI: 10.1177/153100350501700406D.M. Eckmann, S. Kobayashi, M. Li. Microvascular embolization following polidocanol microfoam sclerosant administration. Dermatol Surg, 31 (2005), pp. 636-643Cabrera Garrido, J. La escleroterapia con espuma es un método eficaz para el tratamiento de la insuficiencia venosa. 2016 JOUR Angiología.10.1016/j.angio.2016.01.011Nesbitt C, Bedenis R, Bhattacharya V, Stansby G. Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database of Systematic Reviews. 2014. DOI: 10.1002/14651858.CD005624.pub3MacKenzie RK, Allan PL, Ruckley CV, Bradbury AW. The effect of long saphenous vein stripping on deep venous reflux. Eur J Vasc Endovasc Surg. 2004; 28:104–107. DOI: 10.1016/j.ejvs.2004.03.009Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg 2011;98(8):1079-87. DOI: 10.1002/bjs.7555López-Otín C, Kroemer G.Hallmarks of Health.Cell. 2021;184(1):33-63. doi:10.1016/j.cell.2020.11.034Kaplan R, Criqui M, Denenberg J, Bergan J, Fronek A. Quality of life in patients with chronic venous disease: San Diego population study. Journal of Vascular Surgery 2003; 37: 1047-1053. DOI: 10.1067/mva.2003.168Phyo AZZ, Freak-Poli R, Craig H, et al. Quality of Life and Mortality in the General Population: A Systematic Review and Meta-Analysis.BMC Public Health. 2020;20(1):1596. doi:10.1186/s12889-020 09639-9.Paty J, Turner-Bowker DM, Elash CA, Wright D. The VVSymQ_ instrument: Use of a new patient reported outcome measure for assessment of varicose vein symptoms. Phlebology 2016, Vol. 31(7) 481–488. DOI: 10.1177/0268355515595193Perales F, del Pozo-Cruz J, del Pozo-Cruz J, del Pozo-Cruz B. On the Associations Between Physical Activity and Quality of Life: Findings from an Australian Nationally Representative Panel Survey.Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 2014;23(7):1921-33. doi:10.1007/s11136-014-0645-4.Kiełtyka-Słowik A, Michalik-Marcinkowska U, Zawadzka B. The Association Between Physical Activity and Quality of Life Among People Aged 60-89 Living in Own Homes and Nursing Homes.BMC Geriatrics. 2024;24(1):280. doi:10.1186/s12877-024-04898-2.VILAGUT, Gemma RED-IRYSS et al. El Cuestionario de Salud SF-36 español: una decada de experiencia y nuevos desarrollos. Gac Sanit [online]. 2005, vol.19, n.2, pp.135-150. ISSN 0213-9111Calidad de vida en salud en pacientes con insuficiencia venosa mixta luego de varicosafenectomia, JA Sánchez Monroy. Universidad del Rosario. 2012. http://repository.urosario.edu.co/handle/10336/3629Lamping DL, Schroter S, Kurz X, et al. Evaluation of outcomes in chronic venous disorders of the leg: developmentof a scientifically rigorous, patient- reported measure of symptoms and quality of life. J Vasc Surg 2003; 37: 410–419. DOI: 10.1067/mva.2003.152Rabe E, Pannier F. Societal costs of chronic venous disease in CEAP C4, C5, C6 disease. Phlebology: The Journal of Venous Disease. 2010 25 (S1), 64–67. DOI: 10.1258/phleb.2010.010s09Jaramillo-Vergara V, Carrasco-Uruchima P. Calidad de vida en personas con diagnóstico de insuficiencia venosa crónica que se encuentran en espera de cirugía venosa en el Hospital Eugenio Espejo en el año 2015. Repositorio digital Universidad central del http://www.dspace.uce.edu.ec/handle/25000/10588Todd KL, Wright DI and the VANISH-2 Investigators. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence. Phlebology 2014; 29: 608–618. DOI: 10.1177/0268355513497709VANISH-1: Phase III Study of Polidocanol Endovenous Microfoam on the Appearance of Varicose Veins. Podium presentation by Theodore King, Am Coll Phlebology, 2012Paty J. Elash C, Turner-Bowker D. Content Validity for the VVSymQ Instrument: A New Patient Reported Outcome Measure for the Assessment of Varicose Veins Symptoms Jean. Patient.2017; 10:51–63. DOI: 10.1007/s40271-016-0183-yAber A, Poku E, Phillips P, Essat M, Buckley-Woods H, Palfreyman S. Systematic review of patient reported outcome measures in patients with varicose veins. British Journal of Surgery. 2017; 104(11), 1424–1432. DOI: 10.1002/bjs.10639Dian Andriani Ratna Dewi, Abraham Arimuko, Lilik Norawati. Cureus. Effectiveness of Sclerotherapy to Cure Lower Limb Chronic Venous Insufficiency Grades 1-6: A Systematic Review and Meta Analysis. 2023 Dec 1;15(12): e49770. doi: 10.7759/cureus.49770Paty J, Turner Bowker DM, et al. The VVSymQ® instrument: use of a new patient reported outcome measure for varicose vein symptoms. Phlebology. 2015;30(8):534 45. doi:10.1177/0268355515595193.Sakugawa LS, Portela FSO, Louzada ACS, et al. Polidocanol foam treatment of varicose veins: quality of life impact compared to conventional surgery. Clinics (Sao Paulo). 2024; 79:100346. doi: 10.1016/j.clinsp.2024.100346Todd KL, Wright DI; VANISH 2 Investigators. Durability of treatment effect with polidocanol endovenous microfoam on varicose vein symptoms and appearance (VANISH 2). J Vasc Interv Radiol. 2015;26(5):571 8. doi: 10.1016/j.jvir.2015.02.027Ardeleanu V, Moroianu LA, Curis C, Tatu AL, Ardeleanu IR. The usage of polidocanol in varicose disease treatment. Diagnostics (Basel). 2024;11(2):62. doi:10.3390/diagnostics11020062Rodríguez Garcés CA. La Enfermedad Varicosa. Su tratamiento con radioesclerosis. Rev Colomb Cir. 1998;13(2):104–113. Disponible en: Revista Colombiana de Cirugía, Vol. 13 Núm. 2 (1998)Banchieri A, Betancur J, Bonelli G, Buenahora Y, Castro P, Russo F; supervisores Otero G, Sarutte S, Volpi M. Estudio descriptivo de escleroterapia con polidocanol en pacientes con insuficiencia venosa crónica, entre julio–octubre 2018 en Hospital de Clínicas [Monografía]. Montevideo: Universidad de la https://hdl.handle.net/20.500.12008/33342 República; 2018. Disponible en:https://creativecommons.org/licenses/by-nc-nd/4.0/Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)http://purl.org/coar/access_right/c_abf2oai:repositorio.ucaldas.edu.co:ucaldas/263092025-11-28T08:01:16Z

Efecto en la calidad de vida en pacientes con enfermedad venosa crónica posterior a realización de terapia esclerosante mediante la técnica de Tessari

Publicaciones similares